443 results
Page 5 of 23
424B5
4am0p
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-1.1
wlsy3our4wtwn6w0 8l
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
yh2 1u5fb7sh4hikjk
25 Jan 21
Prospectus supplement for primary offering
4:16pm
UPLOAD
pr4v 6jfrh8eomlx2zb
18 Dec 20
Letter from SEC
12:00am
8-K
EX-10.2
hr6qk
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
424B3
nfm45rc
4 Dec 20
Prospectus supplement
4:48pm
UPLOAD
ndp71jte qa6f
27 Nov 20
Letter from SEC
12:00am
8-K
EX-10.1
pcgd61ff4c0
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
EX-4.1
z4vqe76rz842 z7qm3l
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
424B5
krk0fy5ys
8 Sep 20
Prospectus supplement for primary offering
4:43pm